CliffBio
small molecule

ADVIL

IBUPROFEN SODIUM

Loss of exclusivity—loss of exclusivity
CompanyHaleon →See this company's full patent-cliff portfolio

Drug detail

Brand nameADVIL
Active ingredientIBUPROFEN SODIUM
StrengthEQ 200MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJune 2012
Marketing statusOTC

More from Haleon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.